Risk of hepatitis B virus reactivation in patients treated with anti-TNFα agents for immune-mediated inflammatory diseases.

Actas Dermosifiliogr (Engl Ed)

Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Portugal; Department of Dermatology, Centro Hospitalar do Porto, Portugal. Electronic address:

Published: April 2018

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ad.2017.07.011DOI Listing

Publication Analysis

Top Keywords

risk hepatitis
4
hepatitis virus
4
virus reactivation
4
reactivation patients
4
patients treated
4
treated anti-tnfα
4
anti-tnfα agents
4
agents immune-mediated
4
immune-mediated inflammatory
4
inflammatory diseases
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!